We delivered state-level demand modelling, provider mapping, pricing benchmarks, and epidemiology-linked projections to support healthcare investment and diagnostic strategy.
A healthcare company required a structured assessment of India’s prostate cancer MRI diagnostic market to support expansion planning and investment evaluation across diagnostic networks. Existing information on imaging demand was fragmented, with limited integration between epidemiology, infrastructure availability, pricing structures, and provider distribution.
The client needed a framework capable of explaining both the growth trajectory of prostate cancer diagnostics and the regional disparities in pricing shaping MRI demand across Indian states.
The engagement focused on building a decision-ready intelligence framework rather than simple market size estimates. Key objectives included:
Conducted structured outreach across diagnostic centers and hospitals in multiple Indian states in local languages to collect data on scan volumes, pricing, referral patterns, and infrastructure availability. The process required adapting engagement methods across states due to differences in access, reporting practices, and language.
Validated responses using secondary epidemiology data, provider disclosures, and regional healthcare indicators to ensure consistency between reported utilization and expected diagnostic demand.
Combined primary findings with cancer registry trends, state-level healthcare data and demographic projections to build a state-level model capable of explaining both current diagnostic volumes while mapping future demand.
Demand growth was closely tied to rising cancer incidence and improvements in early detection awareness, rather than purely to technology expansion. This highlighted the importance of demographic and epidemiological drivers in shaping future diagnostic volumes.
The resulting framework enabled the client to transition from a national-level view of the imaging market to a granular, state-level understanding of diagnostic demand and pricing structure.
It provided a basis for evaluating expansion locations, prioritizing diagnostic partnerships, and aligning investment decisions with states showing the strongest combination of incidence growth and infrastructure readiness.